|
MIS12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6574519534629E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.34639990665175E-10 |
| Normal-vs-Stage2 |
7.580700E-03 |
| Normal-vs-Stage3 |
1.354560E-01 |
| Normal-vs-Stage4 |
1.963440E-01 |
| Stage1-vs-Stage2 |
5.109600E-01 |
| Stage1-vs-Stage3 |
8.668200E-02 |
| Stage1-vs-Stage4 |
5.574400E-01 |
| Stage2-vs-Stage3 |
1.094220E-01 |
| Stage2-vs-Stage4 |
4.381600E-01 |
| Stage3-vs-Stage4 |
6.467600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.51720866373262E-12 |
| Normal-vs-AfricanAmerican |
6.14409999999399E-05 |
| Normal-vs-Asian |
2.566200E-01 |
| Caucasian-vs-AfricanAmerican |
6.996200E-01 |
| Caucasian-vs-Asian |
9.645000E-01 |
| AfricanAmerican-vs-Asian |
9.312800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78423942287509E-12 |
| Normal-vs-Female |
4.17270000000469E-05 |
| Male-vs-Female |
3.995400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.502500E-03 |
| Normal-vs-Extreme_Weight |
1.06939999999778E-06 |
| Normal-vs-Obese |
1.8974199999966E-05 |
| Normal-vs-Extreme_Obese |
5.421500E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.194400E-01 |
| Normal_Weight-vs-Obese |
3.335200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.479000E-01 |
| Extreme_Weight-vs-Obese |
7.997600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.888600E-01 |
| Obese-vs-Extreme_Obese |
8.887800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.139110E-03 |
| Normal-vs-Age(41-60Yrs) |
2.61834998127597E-12 |
| Normal-vs-Age(61-80Yrs) |
5.33459999507713E-08 |
| Normal-vs-Age(81-100Yrs) |
9.973200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.243800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.492200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.702100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.196150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.915400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.312500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
9.065400E-01 |
| Normal-VS-KIRP CIMP |
3.496400E-01 |
| Normal-VS-Unclassified PRCC |
1.759270E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.63014046705712E-12 |
| Type1 PRCC-VS-KIRP CIMP |
2.113900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.811700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.707800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.401200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.083400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.218700E-03 |
| Normal-vs-N1 |
1.291640E-02 |
| Normal-vs-N2 |
2.367800E-02 |
| N0-vs-N1 |
3.858800E-01 |
| N0-vs-N2 |
1.307380E-01 |
| N1-vs-N2 |
9.339900E-02 |
|
|
